{"schemaVersion":"ready-scan.discovery-surface.v1","id":"urn:readyscan:corpus:evidence:catalyst-q139885826","key":"evidence:catalyst-q139885826","kind":"evidence","slug":"catalyst-q139885826","canonicalUrl":"https://directory.readyscan.ai/corpus/evidence/catalyst-q139885826","machineUrl":"https://directory.readyscan.ai/discovery/corpus/evidence/catalyst-q139885826.json","datePublished":"2026-07-29","dateModified":"2026-10-24","materialFingerprint":"fnv1a64:276d1a2bcacc4103","membershipFingerprint":"fnv1a64:f2f828749d9be93f","relatedEntitySlugs":["catalyst-q139885826"],"relatedSurfaceKeys":["buyer_question:catalyst-q139885826-answer-11f46393954b2865c716","buyer_question:catalyst-q139885826-answer-149afce15a225a8aed6c","buyer_question:catalyst-q139885826-answer-1879eadd9be98c9d7c02","buyer_question:catalyst-q139885826-answer-3c33d96996b850d01828","buyer_question:catalyst-q139885826-answer-5a9e31bda2357834115b","buyer_question:catalyst-q139885826-answer-6daeda7912fea6157cbd","buyer_question:catalyst-q139885826-answer-7546100b22fa65a8c1ef","buyer_question:catalyst-q139885826-answer-7e2dc8e987685701318e","buyer_question:catalyst-q139885826-answer-f5f83f29158d71ef08a4"],"sourceIds":["ready-scan-subjects"],"provenance":[{"snapshotId":"catalyst-q139885826-content-710f9c4b1673a68c-snapshot","sourceId":"ready-scan-subjects","sourceRecordId":"Q139885826","sourceRevisionId":"Q139885826:content:47f2f3e6b3fbe436","sourceContentHash":"fnv1a64:2a332fa987a77f88","recordRevisionId":"Q139885826:content:47f2f3e6b3fbe436","recordContentHash":"fnv1a64:ecd3ba7bc72c029d","sourceCanonicalUrl":"https://catalystexplains.com/","sourceModifiedAt":"2026-10-24T05:35:55.461Z","observedOn":"2026-10-24","permission":{"basis":"public_information","evidenceUrl":"https://catalystexplains.com/"},"attributionUrl":"https://catalystexplains.com/"}],"quality":{"method":"same_kind_unique_trigram_floor","minimumUniqueTrigramRatio":0.3,"status":"passed"},"title":"Catalyst — company guide","summary":"Catalyst: Houston-based U.S. company combining GLP-class peptide commerce with science-explainer publishing on peptide therapeutics. Website: https://catalystexplains.com.","facts":[{"id":"content-native-digital-agencies-bd8118dce10aa767-a-f5f83f29158d71ef08a4","label":"Where should I start?","value":"“Start with Science Explained for foundational guides, Peptide News for current developments, or the GLP-3 Overview for a focused introduction to the next generation of GLP research.”","sourceUrls":["https://catalystexplains.com/"]},{"id":"content-native-digital-agencies-bd8118dce10aa767-a-7e2dc8e987685701318e","label":"What is Science Explained?","value":"“Science Explained is a library of visual, plain-language guides to peptide biology, GLP mechanisms, myths, and the questions readers ask most.”","sourceUrls":["https://catalystexplains.com/"]},{"id":"content-native-digital-agencies-bd8118dce10aa767-a-11f46393954b2865c716","label":"What is Peptide News?","value":"“Peptide News follows the research, companies, policy decisions, and market developments shaping the peptide category.”","sourceUrls":["https://catalystexplains.com/"]},{"id":"content-native-digital-agencies-bd8118dce10aa767-a-149afce15a225a8aed6c","label":"What is the GLP-3 Overview?","value":"“The GLP-3 Overview is a focused introduction to triple-receptor research and how GLP-1, GIP, and glucagon pathways are studied together.”","sourceUrls":["https://catalystexplains.com/"]},{"id":"content-native-digital-agencies-bd8118dce10aa767-a-3c33d96996b850d01828","label":"What does “third generation” mean?","value":"“In Catalyst's GLP-3 coverage, third generation describes research built around three receptor pathways: GLP-1, GIP, and glucagon.”","sourceUrls":["https://catalystexplains.com/faq/"]},{"id":"content-native-digital-agencies-bd8118dce10aa767-a-7546100b22fa65a8c1ef","label":"Why do newer GLP compounds target more than one receptor?","value":"“Researchers are studying whether combining complementary metabolic signals can produce broader effects than targeting a single pathway alone.”","sourceUrls":["https://catalystexplains.com/faq/"]},{"id":"content-native-digital-agencies-bd8118dce10aa767-a-1879eadd9be98c9d7c02","label":"Where can I go deeper?","value":"“Science Explained articles connect related guides and cited sources so readers can move from a plain-language introduction into the underlying research.”","sourceUrls":["https://catalystexplains.com/faq/"]},{"id":"content-native-digital-agencies-bd8118dce10aa767-a-5a9e31bda2357834115b","label":"What is changing in the GLP market?","value":"“The category is moving from single-receptor medicines toward dual- and triple-receptor research, while new delivery formats, indications, and access models continue to develop.”","sourceUrls":["https://catalystexplains.com/faq/"]},{"id":"content-native-digital-agencies-bd8118dce10aa767-a-6daeda7912fea6157cbd","label":"Where can I follow new GLP developments?","value":"“Peptide News covers current developments, while Science Explained provides the deeper background needed to understand why they matter.”","sourceUrls":["https://catalystexplains.com/faq/"]},{"id":"source-description","label":"About","value":"Houston-based U.S. company combining GLP-class peptide commerce with science-explainer publishing on peptide therapeutics.","sourceUrls":["https://www.wikidata.org/wiki/Special:EntityData/Q139885826.json?revision=2495847818"]},{"id":"source-listed-website","label":"Website","value":"https://catalystexplains.com","sourceUrls":["https://www.wikidata.org/wiki/Special:EntityData/Q139885826.json?revision=2495847818"]}]}